Estimate of the cost per responder for treatment with biological therapies of moderate-to-severe plaque psoriasis in Colombia for first-year and maintenance periods.

Saved in:
Bibliographic Details
Title: Estimate of the cost per responder for treatment with biological therapies of moderate-to-severe plaque psoriasis in Colombia for first-year and maintenance periods.
Authors: Lasalvia P; Department of Health Economics, Neuroeconomix, Bogota, Colombia., Gil-Rojas Y; Department of Health Economics, Neuroeconomix, Bogota, Colombia., Papadimitropoulos E; Value Evidence and Outcomes, Eli Lilly and Company, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada., Burge R; Value Evidence and Outcomes, Eli Lilly and Company, Indianapolis, Indiana, USA.; Division of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, Ohio, USA., Rosselli D; Department of Health Economics, Neuroeconomix, Bogota, Colombia.; Faculty of Medicine, Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Hospital San Ignacio, Bogota, Colombia.
Source: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2023 Jun; Vol. 23 (5), pp. 511-517. Date of Electronic Publication: 2023 Mar 29.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-8379
DOI:10.1080/14737167.2023.2190514